Zobrazeno 1 - 10
of 20
pro vyhledávání: '"D. V. Skarlos"'
Autor:
Lesley A. Stewart, S. B. Kaye, S. Pecorelli, N. Colombo, C. Mangioni, R. V. Smalley, B. Y. Yeap, D. W. Wilbur, R. C. Leonard, M. F. Brady, E. Wiltshaw, P. F. Conte, S. Marsoni, J. F.G. Sturgeon, M. H.N. Tattersall, C. Gennatas, C. Trope, A. Athanazziou, D. Guthrie, D. Crowther, D. R. Bell, A. H. Laing, M. Gore, J. B. Vermorken, C. Lewis, E. Gilbey, Giorgio Bolis, H. Bruckner, P. Adnitt, M. K.B. Parmar, M. Tomirotti, H. Meerpohl, H. S. Brodovsky, W. Sauerbrei, J. Pater, R. Canetta, W.W. ten Bokkel Huinink, D. V. Skarlos, H. J. Solomon, M. J. Webb, J. T. Wharton, F. Landoni, P. Y. Liu, M. M. Turbow, J. H. Edmonson, D. S. Alberts, C. J. Cohen, K. Aabo, W. Torri, V. Barley, M. Adams, M. Buyse, C. J. Williams, M. Presti, V. Chylak, U. Bianchi, G. A. Omura
Publikováno v:
Scopus-Elsevier
The purpose of this systematic study was to provide an up to date and reliable quantitative summary of the relative benefits of various types of chemotherapy (non-platinum vs platinum, single-agent vs combination and carboplatin vs cisplatin) in the
Autor:
J. Elemenoglou, D. V. Skarlos, H Zorzos, A. Bakiras, M. Likourinas, D. Pectasidis, A. Zizi, J. Zorzos
Publikováno v:
European Urology. 28:251-254
The expression of a cell surface antigen recognized by the epithelium-specific, tumor-associated monoclonal antibody (Moab) AUA1 has been studied in 22 cases of normal urothelium, 7 cases of dysplastic urothelium and 86 cases of transitional cell car
Autor:
D, Pectasides, G, Papaxoinis, G, Fountzilas, G, Aravantinos, A, Bamias, N, Pavlidis, H P, Kalofonos, E, Timotheadou, E, Samantas, E, Briasoulis, D V, Skarlos, T, Economopoulos, M A, Dimopoulos
Publikováno v:
Anticancer research. 29(2)
The aim of this retrospective study was to present the epidemiological, pathological and clinical characteristics and treatment results of Greek women with epithelial ovarian cancer (EOC).From February 1976 to December 2006, 1,791 patients had been d
Publikováno v:
Anticancer research. 27(4C)
Admission of cancer patients with serious medical complications to the Intensive Care Unit (ICU) remains controversial. The aim of this study was to examine the 30-day all-cause mortality in cancer patients with solid tumors admitted to the ICU and t
Publikováno v:
Anticancer research. 23(1B)
To evaluate the efficacy and safety of weekly paclitaxel and trastuzumab in patients with HER2-positive metastatic breast cancer, with trastuzumab administered beyond disease progression.Twenty-six women with metastatic breast cancer, that was HER2-p
Autor:
C, Christodolou, N, Pavlidis, E, Samantas, G, Fountzilas, G, Kouvatseas, K, Pagdatoglou, F, Palamidas, C, Nikolaidis, M, Angelidou, H P, Kalofonos, P, Kosmidis, D V, Skarlos
Publikováno v:
Anticancer research. 22(6B)
Prognostic factors among Greek patients with SCLC were evaluated.Data from 516 patients with SCLC treated by the Hellenic Cooperative Oncology Group were analyzed. Multivariate analysis was performed.Complete response (CR) was achieved in 26.8% and p
Autor:
D V, Skarlos, G, Aravantinos, P, Kosmidis, A, Athanassiadis, G P, Stathopoulos, N, Pavlidis, D, Bafaloukos, S, Karphathios, P, Papakostas, C, Bamia, G, Fountzilas
Publikováno v:
Seminars in oncology. 24(5 Suppl 15)
Ninety previously untreated patients with advanced epithelial ovarian cancer (International Federation of Gynecology and Obstetrics stages IIC, III, and IV) were randomized, after initial cytoreductive surgery, to receive paclitaxel (Taxol; Bristol-M
Autor:
D V, Skarlos, G, Aravantinos, E, Linardou, C A, Kostakopoulos, I, Kastriotis, C, Christodoulou, D, Picramenos, T, Giannakakis, K, Dimopoulos, G, Fountzilas
Publikováno v:
European urology. 31(4)
We conducted a phase II study in order to assess the efficacy and toxicity of Carbo-MVE (carboplatin 250 mg/m2 i.v. day 1, methotrexate 25 mg/m2 i.v. days 1, 15 and 22, vinblastine 2.5 mg/m2 i.v. days 1, 15 and 22 and epirubicin 25 mg/m2 day 1). The
Autor:
D V, Skarlos, E, Samantas, P, Kosmidis, G, Fountzilas, M, Angelidou, P, Palamidas, N, Mylonakis, A, Provata, E, Papadakis, G, Klouvas
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 5(7)
To compare the efficacy and toxicity of etoposide and cisplatin (EP) with etoposide and carboplatin (EC) in combination with irradiation in small-cell lung cancer (SCLC).Previously untreated patients (pts) with SCLC and measurable or evaluable diseas
Autor:
P, Kosmidis, N, Mylonakis, D V, Skarlos, E, Samantas, M, Beer, D, Theocharis, E, Zachariadis, A, Gioti, E, Papadakis, N, Poulakis
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 5(2)
To evaluate the efficacy and toxicity of ifosfamide in combination with cisplatin and vinblastine in non-operable non-small-cell lung cancer (NSCLC).A total of 136 patients with stage III or IV NSCLC were randomized to either PV (cisplatin, 120 mg/m2